Girgenti Rosario, Buttafarro Maria Antonina, Ammirata Martina, La Russa Antonino, Agnese Valentina, Messina Margaret
ISMETT - Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione, IRCCS, Palermo.
G Ital Cardiol (Rome). 2021 Mar;22(3):233-238. doi: 10.1714/3557.35343.
Left ventricular assist devices (LVAD) are the most common mechanical circulatory support for patients with advanced heart failure, and can be used either as a temporary or permanent therapy. Normally, LVAD carriers show psychological distress related to the difficulties in adapting to their new clinical condition.
This retrospective study aimed to analyze the quality of life of 21 patients after LVAD implantation and follow-up in a dedicated psychology outpatient clinic. The Short Form Health Survey (SF-36) was used to assess the quality of life, and the Hospital Anxiety and Depression Scale (HADS) to measure anxiety and depression levels. These constructs were examined according to the time of implant and their age, with correlational analyses.
Outcomes seem to affect the quality of life of our population when compared with regulatory data, in terms of both physical health and mental health. Patient age was inversely related to the mental health index (Pearson's correlation coefficient -0.48, p<0.05) and two subscales, i.e. "vitality" (Pearson's correlation coefficient -0.60, p<0.05) and "mental health" (Pearson's correlation coefficient -0.44, p<0.05). The most critical areas included physical pain and social limitations. The overall incidence of anxiety and depression was within normal limits according to the HADS test: LVAD patients supported for less than 1 year showed a lower incidence of anxiety compared with LVAD carriers supported for more than 1 year, while the incidence of depression was higher compared with LVAD carriers supported for more than 1 year.
LVAD negatively impact physical and mental health, 'especially in older people; the scores obtained at SF-36, both for the physical health index and the mental health index, show lower average values than the regulatory standard. In addition, the depression levels vary based on the time elapsed from the date of implantation confirming the need for continuous monitoring of patients during treatment to prevent an increase of this index over the years. This patient subset requires continuing support and careful psychological monitoring, from preliminary assessment to LVAD implant, and later over the entire therapeutic process.
左心室辅助装置(LVAD)是晚期心力衰竭患者最常见的机械循环支持设备,可作为临时或永久治疗手段使用。通常情况下,LVAD使用者会因难以适应新的临床状况而出现心理困扰。
这项回顾性研究旨在分析21例LVAD植入术后患者在专门的心理门诊接受随访时的生活质量。采用简短健康调查问卷(SF-36)评估生活质量,并用医院焦虑抑郁量表(HADS)测量焦虑和抑郁水平。根据植入时间和年龄对这些指标进行检查,并进行相关性分析。
与标准数据相比,我们研究人群的生活质量在身体健康和心理健康方面似乎都受到了影响。患者年龄与心理健康指数呈负相关(皮尔逊相关系数为-0.48,p<0.05),与两个子量表即“活力”(皮尔逊相关系数为-0.60,p<0.05)和“心理健康”(皮尔逊相关系数为-0.44,p<0.05)也呈负相关。最关键的方面包括身体疼痛和社交限制。根据HADS测试,焦虑和抑郁的总体发生率在正常范围内:与支持时间超过1年的LVAD使用者相比,支持时间少于1年的LVAD患者焦虑发生率较低,而抑郁发生率则较高。
LVAD对身心健康有负面影响,尤其是对老年人;SF-36在身体健康指数和心理健康指数方面获得的分数显示,平均值低于标准水平。此外,抑郁水平会根据植入日期后的时间长短而变化,这证实了在治疗期间需要持续监测患者,以防止该指数多年来上升。这类患者从初步评估到LVAD植入,以及随后的整个治疗过程都需要持续的支持和仔细的心理监测。